<DOC>
	<DOCNO>NCT00413790</DOCNO>
	<brief_summary>This study evaluate pharmacologic effect exposure darifenacin tolterodine cardiovascular parameter healthy subject 50 year age old</brief_summary>
	<brief_title>Pharmacologic Effects Darifenacin Tolterodine Cardiovascular Parameters Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<mesh_term>Darifenacin</mesh_term>
	<criteria>Healthy male female â‰¥ 50 year Body mass index equal great 18.5 kg/m2 less 35.0 kg/m2 Known suspect allergy tolterodine ER darifenacin component Subjects irregular day night pattern night shift worker Significant medical problem know affect heart rate ( ie. , hypertension , hypotension , history heart failure , history pulmonary disease , etc . ) History malignancy within past 5 year , exception localize basal cell carcinoma skin Pregnant nursing woman Subjects disease urinary retention , gastric retention , uncontrolled narrowangle glaucoma , severe renal insufficiency , etc . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Heart rate , overactive bladder</keyword>
</DOC>